SARAH FALK: Open Payments
NPI 1932469319 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,953 in 92 payments from 19 companies in 2025. Trend: 2023 $1,481 · 2024 $1,442 · 2025 $1,953
Food & beverage: $1,953
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 20 | $427 |
| Novo Nordisk Inc | 14 | $336 |
| Abbott Laboratories | 17 | $213 |
| Corcept Therapeutics | 6 | $161 |
| Ascendis Pharma Endocrinology Inc | 1 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $94 |
| Radius Health, Inc. | 5 | $92 |
| SANOFI-AVENTIS U.S. LLC | 4 | $76 |
| IBSA Pharma Inc. | 3 | $73 |
| Amgen Inc. | 4 | $62 |
Products named: MOUNJARO, JARDIANCE, Wegovy, FREESTYLE LIBRE 3, Korlym, Yorvipath, Ozempic, Tymlos.
Industry payments across NC — which companies pay providers there.
